SMTL ID : 5i2k.1

Structure of the human GluN1/GluN2A LBD in complex with 7-{[ethyl(4-fluorophenyl)amino]methyl}-N,2-dimethyl-5-oxo-5H-[1,3]thiazolo[3,2-a]pyrimidine-3-carboxamide (compound 19)

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.86 Å

Oligo State

hetero-1-1-mer

Ligands

1 x GLU: GLUTAMIC ACID(Non-covalent)

GLU.1: 10 residues within 4Å: Chain A: H.87, S.113, L.114, T.115, R.120, G.171, S.172, T.173, Y.213, D.214 14 PLIP interactions: 13 interactions with chain A, 1 Ligand-Ligand interactions Hydrophobic interactions: A:Y.213, A:D.214 Hydrogen bonds: A:S.113, A:T.115, A:T.115, A:T.115, A:S.172, A:T.173, A:T.173, A:D.214, E.1 Water bridges: A:E.174 Salt bridges: A:H.87, A:R.120

1 x GLY: GLYCINE(Non-covalent)

GLY.2: 10 residues within 4Å: Chain B: F.93, P.125, L.126, T.127, R.132, S.180, S.181, W.224, D.225, F.251 5 PLIP interactions: 5 interactions with chain B Hydrogen bonds: B:T.127, B:T.127, B:S.181, B:D.225 Salt bridges: B:R.132

1 x 67H: 7-{[ethyl(4-fluorophenyl)amino]methyl}-N,2-dimethyl-5-oxo-5H-[1,3]thiazolo[3,2-a]pyrimidine-3-carboxamide(Non-covalent)

67H.3: 17 residues within 4Å: Chain A: I.116, P.129, F.130, V.131, E.132, T.241, T.242, G.243, L.263, V.266 Chain B: K.140, P.141, K.143, Y.144, G.250, L.270, H.273 8 PLIP interactions: 5 interactions with chain B, 3 interactions with chain A Hydrophobic interactions: B:K.140, B:P.141, B:L.270, A:P.129, A:T.241 pi-Stacking: B:Y.144, B:Y.144 Hydrogen bonds: A:P.129

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Volgraf, M. et al., Discovery of GluN2A-Selective NMDA Receptor Positive Allosteric Modulators (PAMs): Tuning Deactivation Kinetics via Structure-Based Design. J.Med.Chem. (2016)

Release Date

2016-03-16

Peptides

Glutamate receptor ionotropic, NMDA 2A: A
Glutamate receptor ionotropic, NMDA 1: B

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

Glutamate receptor ionotropic, NMDA 2A

Glutamate receptor ionotropic, NMDA 1

Related Entries With Identical Sequence